Nutex Health Inc. (NASDAQ:NUTX - Get Free Report)'s share price reached a new 52-week high on Wednesday after Maxim Group raised their price target on the stock from $75.00 to $100.00. Maxim Group currently has a buy rating on the stock. Nutex Health traded as high as $99.00 and last traded at $94.98, with a volume of 88438 shares trading hands. The stock had previously closed at $84.94.
Institutional Trading of Nutex Health
Hedge funds have recently modified their holdings of the company. Bank of America Corp DE raised its position in Nutex Health by 6,590.3% in the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock worth $66,000 after purchasing an additional 2,043 shares in the last quarter. Beaird Harris Wealth Management LLC bought a new position in shares of Nutex Health during the 3rd quarter worth approximately $69,000. Geode Capital Management LLC grew its position in Nutex Health by 12.6% in the fourth quarter. Geode Capital Management LLC now owns 34,125 shares of the company's stock valued at $1,082,000 after acquiring an additional 3,826 shares during the period. Northern Trust Corp acquired a new position in Nutex Health during the fourth quarter worth $200,000. Finally, Truist Financial Corp lifted its holdings in shares of Nutex Health by 22.2% during the fourth quarter. Truist Financial Corp now owns 35,570 shares of the company's stock valued at $1,127,000 after acquiring an additional 6,454 shares during the period. Institutional investors own 5.32% of the company's stock.
Nutex Health Price Performance
The company's 50 day moving average price is $62.62 and its 200 day moving average price is $42.08. The company has a debt-to-equity ratio of 3.36, a quick ratio of 1.74 and a current ratio of 1.77. The company has a market cap of $691.28 million, a price-to-earnings ratio of -13.32 and a beta of 0.27.
Nutex Health (NASDAQ:NUTX - Get Free Report) last released its quarterly earnings results on Monday, March 31st. The company reported $11.12 earnings per share for the quarter, beating analysts' consensus estimates of ($0.09) by $11.21. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%. The firm had revenue of $81.30 million during the quarter, compared to analysts' expectations of $81.13 million.
About Nutex Health
(
Get Free Report)
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
See Also
Before you consider Nutex Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.
While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
